Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

COPD: current therapeutic interventions and future approaches.

P J Barnes1, R A Stockley

  • 1National Heart and Lung Institute, Imperial College School of Medicine, Dovehouse St, London SW3 6LY, UK. p.j.barnes@imperial.ac.uk

The European Respiratory Journal
|June 3, 2005
PubMed
Summary

New treatments targeting inflammation are in development for chronic obstructive pulmonary disease (COPD). These novel therapies aim to reduce COPD progression and suppress lung inflammation, unlike current bronchodilators.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucocorticoid resistance in asthma.

American journal of respiratory and critical care medicine·1995
Same author

Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.

The Journal of experimental medicine·1995
Same author

Inhibition of macrophage inflammatory protein-1 alpha expression by IL-10. Differential sensitivities in human blood monocytes and alveolar macrophages.

Journal of immunology (Baltimore, Md. : 1950)·1995
Same author

Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.

Molecular pharmacology·1995
Same author

Corticosteroid inhibition of macrophage inflammatory protein-1 alpha in human monocytes and alveolar macrophages.

The American journal of physiology·1995
Same author

Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction.

Thorax·1995

Area of Science:

  • Pulmonary Medicine
  • Inflammation Research
  • Pharmacology

Background:

  • Long-acting bronchodilators are standard for chronic obstructive pulmonary disease (COPD) but do not address underlying inflammation.
  • Current COPD treatments fail to reduce disease progression or suppress inflammation in small airways and lung parenchyma.

Purpose of the Study:

  • To review emerging therapies targeting the inflammatory processes in COPD.
  • To highlight novel treatments in clinical development for COPD management.

Main Methods:

  • Review of clinical development pipelines for COPD treatments.
  • Categorization of therapies based on their molecular targets (e.g., chemokine antagonists, cytokine inhibitors, enzyme inhibitors).

Main Results:

Related Experiment Videos

  • Several anti-inflammatory strategies are in Phase III development, including phosphodiesterase-4 inhibitors.
  • Other promising targets include p38 MAPK, NF-kappaB, PI3K-gamma, antioxidants, iNOS, LTB4, and inhibitors of serine proteinase and MMPs.
  • Therapies addressing mucus hypersecretion and lung destruction are also under investigation.

Conclusions:

  • Novel anti-inflammatory and disease-modifying treatments are advancing for COPD.
  • Further research into COPD mechanisms, biomarkers, and monitoring is crucial for therapeutic development.